Lyra doubles valuation in 5 months; Fertility freedom might have negative consequences

Invent Health with Dr. Archana Dubey and Bambi Francisco Roizen; Episode 9

The Invent Health weekly podcast with Dr. Archana Dubey and Bambi Francisco Roizen is the only weekly podcast that breaks down the latest digital health news of the week and what it means for patients, providers and payers (or who's paying). Plus a deep dive on a particular topic to help listeners understand how innovation is changing the healthcare paradigm.

This week, the duo focus on some big announcements: Lyra raises $200 million and doubles its market valuation to $4.6 billion in a few months. How it's different from Ginger as it leverages the traditional EAP (employee assistant program) market. One Medical buys Iora Health for more than $2 billion and why this acquisition positions them in the growing Medicare Advantage market. According to CMS, the number of seniors grows to 70 million by 2025, up from 62 million in 2020. Letsgetchecked.com lands $150 million to expand beyond at-home testing. Transcarent raises $58 million to empower employees to know how to navigate the different healthcare apps and options offered by their employers. 

The deep dive this week is on the booming fertility market as Ro buys Modern Health and Future Family raising $9 million. They get into a philosophical discussion of whether having the option of having an on-demand family is ultimately good for families or whether unintended negative consequences are worth the freedom. 

Editor's note: On July 14, we'll continue our Future of Mental and Behavioral Health 2021 virtual series. This year's event hosted top-level VCs and C-level executives from the leading mental and behavioral companies, such as Teladoc's BetterHelp, BetterUp, Ginger, Amwell, Doctor on Demand, Kaiser Permanente, Bessemer Ventures and more.